Awarded $8.5M Judgment Against Former Licensee
As a licensee, JingJing Genetics Inc. (formerly IND Lifetech Inc.) was granted the right to use XY's sperm sorting technology to manufacture and sell bovine sexed semen and sexed embryos, while maintaining strict control over XY confidential information. Following a long trial (XY LLC v. International Newtech Development, case no. S076862), the British Columbia Supreme Court found that JingJing violated its contract obligations by multiple breaches of the license agreement and found JingJing's principals liable for civil fraud and conspiracy to cause economic injury. The Court awarded XY $8.5 million dollars in damages, additional special costs, and a permanent injunction against JingJing and its principals to cease using any of XY's proprietary research and technology, including but not limited to XY's information and techniques relating to the production and use of cattle embryos made from sexed semen. XY was represented by Chris Wilson and Geoff Bowman of Bull Housser based in Vancouver, Canada.
XY has made its mark in the reproductive world by commercializing efficient methods and equipment for sorting sperm into X- (female) and Y- (male) chromosome bearing cell populations. XY's sperm sorting technology has transformed the world of beef and dairy cattle with efficient gender-selective breeding. The technology has been used successfully in numerous species with over 90% purity. XY licenses out its sperm sorting technology to breeders worldwide, with major markets in North and South America, Europe, Asia, Australia, and New Zealand.
The information in this press release is historical in nature and is current only to the date indicated in the press release. To the extent permitted by law, XY LLC and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.
About XY, LLC
XY LLC, based in Fort Collins, Colorado, USA, has emerged as the world leader in the research, development and commercialization of XY(R) sex selection technology in non-human mammals, including cattle, horses, pigs, and endangered species.
XY LLC is the master licensee in control of all sperm sorting in non-human mammals worldwide. The XY sex selection technology creates the ability to choose the sex of the offspring using sexed semen or sexed embryos.
We are committed to excellence in the advancement of reproductive science and in service to XY LLC licensees worldwide.